| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Teva Pharmaceutical Industries Ltd (TEVA) has 22 insiders with recent SEC Form 4 filings, including 0 buys and 12 sells. TEVA is classified in the Pharmaceuticals industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Dir | 426.3K | $15.42M | - | |
| CFO | 403.3K | $14.59M | - | |
| Dir | 367.6K | $13.30M | - | |
| VP | 148.8K | $5.38M | - | |
| Dir | 115.7K | $4.18M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Aug 9, 2024 | Hughes Eric A | See "remarks" | Sell | 45,060 | $17.38 | $782,971.57 | -100% | +0.4% | -6.1% | |
| Aug 9, 2024 | Grant Angus | EVP, Business Development | Sale+OE | 4,065 | $17.28 | $70,243.20 | -31.5% | +0.4% | -6.1% | |
| Aug 1, 2024 | Hughes Eric A | See "remarks" | Sale+OE | 24,537 | $17.25 | $423,280.43 | -35.3% | +6.0% | -12.3% | |
| Jun 18, 2024 | Mignone Roberto | Director | Sell | 519,000 | $17.03 | $8,838,570.00 | -34.6% | +6.2% | +0.3% | |
| May 16, 2024 | Weiss Amir | Chief Accounting Officer | Sell | 28,135 | $16.73 | $470,793.59 | -55.0% | +10.5% | +3.9% | |
| May 13, 2024 | Conway Vikki L | See "remarks" | Sell | 15,219 | $16.74 | $254,807.15 | -100% | +1.2% | +3.6% | |
| Mar 6, 2024 | Kalif Eliyahu Sharon | EVP, Chief Financial Officer | Sale+OE | 77,550 | $13.52 | $1,048,119.27 | -27.6% | +22.9% | +13.5% | |
| Mar 5, 2024 | Daniell Richard | Exec. VP, European Commercial | Sale+OE | 48,629 | $13.52 | $657,240.39 | -22.4% | +25.4% | +17.4% | |
| Mar 5, 2024 | Conway Vikki L | See "remarks" | Sale+OE | 1,427 | $13.52 | $19,286.48 | -8.6% | +25.4% | +17.4% | |
| Mar 5, 2024 | Sabag Mark | EVP, International Markets | Sale+OE | 100,000 | $13.52 | $1,352,090.00 | -20.7% | +25.4% | +17.4% |